Chronic wounds are characterized by persistent inflammation and excessive levels of reactive oxygen species (ROS), which create a vicious cycle that impedes healing. Effective management of these factors is paramount for successful wound closure and tissue regeneration. NINGBO INNO PHARMCHEM CO.,LTD. is at the forefront of developing targeted inflammation and ROS management therapies designed to break this cycle and accelerate recovery.


Our innovative dimeric copper peptide incorporated hydrogel stands as a prime example of such a targeted therapy. This advanced biomaterial functions as a powerful anti-inflammatory hydrogel for wound repair, actively reducing pro-inflammatory cytokines and promoting a shift towards reparative macrophage phenotypes. This modulation of the immune response is crucial for reducing chronic inflammation that delays healing.


Simultaneously, the hydrogel excels as an antioxidant hydrogel for diabetic wounds, possessing robust ROS-scavenging capabilities. By neutralizing harmful free radicals, it protects healthy tissue from oxidative damage and creates a more conducive environment for cellular proliferation and migration. This dual action of inflammation and ROS management is what sets our solution apart, offering a comprehensive approach to challenging chronic wounds.


For clinicians and researchers looking for a reliable ROS management therapies supplier, NINGBO INNO PHARMCHEM CO.,LTD. provides high-quality Ghk-Cu materials and finished hydrogel products. We are committed to supplying ingredients that are backed by extensive research and demonstrate superior efficacy in preclinical and clinical studies. Our materials are designed to enhance the body's natural healing mechanisms, leading to faster wound closure and improved tissue quality.


If you aim to buy anti-inflammatory wound care solutions that offer a precise and effective way to tackle the complex pathology of chronic wounds, NINGBO INNO PHARMCHEM CO.,LTD. is your trusted partner. Our dedication to innovation ensures that we continue to provide advanced therapies that significantly improve outcomes for patients suffering from long-standing wounds, bringing science-backed healing to the forefront of medical care.